Pila Pharma (public company)

See something wrong or missing? Let us know
Offices:Malmö
Business model:B2B

Pila Pharma aims to develop a new and superior tablet-based treatment for diabetes.

Pila Pharma is listed locally on the stock exchange in Stockholm.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.91M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Pila Pharma

Name Criteria
France Pharmedigroup
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Cinclus Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Sweden iCellate
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Denmark Octarine Bio
65%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Causaly
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
France Xenothera
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
France AbolerIS Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top